StatSeal

Biolife is a medical device company that develops and manufactures patented hemostatic products under the brand names StatSeal and WoundSeal. Headquartered in Sarasota, Florida, the company's core technology utilizes a mixture of potassium ferrate and a hydrophilic polymer to create an instant, occlusive seal over wounds and vascular access sites. Unlike traditional hemostats, Biolife's products work independently of the body's natural clotting cascade, providing effective bleeding control for patients on anticoagulants or with clotting disorders. The company's solutions are widely used in interventional cardiology, radiology, and for indwelling catheter maintenance to reduce hold times and complications. In May 2025, Biolife was acquired by Merit Medical Systems for $120 million, integrating its products into Merit's global vascular access and procedure portfolio.